Edition:
United Kingdom

Galectin Therapeutics Inc (GALT.OQ)

GALT.OQ on NASDAQ Stock Exchange Capital Market

4.69USD
21 Aug 2018
Change (% chg)

$0.24 (+5.39%)
Prev Close
$4.45
Open
$4.50
Day's High
$5.07
Day's Low
$4.49
Volume
175,638
Avg. Vol
150,831
52-wk High
$9.49
52-wk Low
$1.29

Chart for

About

Galectin Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in drug research and development to create therapies for fibrotic disease and cancer. The Company's drug candidates are based on its method of targeting galectin proteins, which are mediators of biologic and pathologic functions. It uses naturally... (more)

Overall

Beta: 2.56
Market Cap(Mil.): $146.06
Shares Outstanding(Mil.): 37.74
Dividend: --
Yield (%): --

Financials

  GALT.OQ Industry Sector
P/E (TTM): -- 98.72 30.39
EPS (TTM): -0.43 -- --
ROI: -190.97 0.92 12.61
ROE: -- -0.89 14.80

BRIEF-Galectin Therapeutics Provides Business Update

* GALECTIN THERAPEUTICS REPORTS 2017 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

29 Mar 2018

Competitors

Earnings vs. Estimates